Background: Basal cell carcinoma (BCC) is a frequently diagnosed skin cancer with variable histopathological types. BCC was not widely studied in Sudan as it is in the Caucasian population. Objectives: To appraise the...Background: Basal cell carcinoma (BCC) is a frequently diagnosed skin cancer with variable histopathological types. BCC was not widely studied in Sudan as it is in the Caucasian population. Objectives: To appraise the clinical and histopathological aspects of BCC of the skin in Sudan. Materials and methods: A retrospective descriptive analysis of 84 histologically diagnosed BCC specimens seen at three hospitals in four-year duration were reviewed and classified into histological variants according to the WHO classification 2006. Data were analyzed using Statistical Package for the Social Sciences, version 23.0. Results: The mean age (±SD) of the study participants was 56 (±1.75) years, ranging from 20 to 92 years and 63.1% were females (Female to male ratio 1.7:1). The most common incidence was among the age group 51 - 60 years. The face was the primary tumor site in 89.3% with a predilection for the nasal area (31% of those in the face), followed by the trunk (6%). Out of the total, 54.8% were histologically categorized as nodular/solid, while infiltrative accounts for 11.9% followed by the superficial type (8.3%). Surgical margins were involved in 34.5% of cases and peri-neural invasion was seen in 3.6% of cases, mostly were of the infiltrative variant. Conclusion: BCC in Sudan is commonly present in the head as solid nodular histopathological variant which is correlated with worldwide distribution but has slightly younger age and female predominance;thus further studies are needed to assess risk factors in Sudanese patients and improve approaches for earlier diagnosis and better management.展开更多
目的:观察化痰散瘀汤治疗斑块型银屑病(痰瘀互结证)的临床疗效及临床作用机制。方法:将皮肤科斑块型银屑病(痰瘀互结证)患者80例按随机数字表法分为观察组与对照组各40例。对照组予阿维A胶囊+糠酸莫米松软膏治疗,观察组在此基础上予化...目的:观察化痰散瘀汤治疗斑块型银屑病(痰瘀互结证)的临床疗效及临床作用机制。方法:将皮肤科斑块型银屑病(痰瘀互结证)患者80例按随机数字表法分为观察组与对照组各40例。对照组予阿维A胶囊+糠酸莫米松软膏治疗,观察组在此基础上予化痰散瘀汤治疗。观察两组患者中医证候评分(皮损颜色、皮损肥厚浸润、瘙痒、肌肤甲错),银屑病皮损面积和严重程度指数(psoriasis area and severity index,PASI)评分,皮肤病生活质量指数调查表(dermatology life quality index,DLQI)评分,血清免疫细胞因子干扰素γ(interferonγ,IFN-γ)、白细胞介素4(interleukin 4,IL-4)、白细胞介素17A(interleukin 17A,IL-17A)、白细胞介素10(interleukin-10,IL-10)、白细胞介素22(interleukin-22,IL-22)改善状况,并统计临床疗效及不良反应发生情况。结果:两组治疗后皮损颜色、皮损肥厚浸润、瘙痒、肌肤甲错积分均明显降低(P<0.05),且观察组治疗后中医证候积分明显低于对照组(P<0.05)。两组治疗后PASI及DLQI评分均明显降低(P<0.05),且观察组明显低于对照组(P<0.05)。两组治疗后血清IFN-γ、IL-17A、IL-22水平均明显降低(P<0.05),IL-4及IL-10水平均明显升高(P<0.05),且观察组上述指标改善情况均优于对照组(P<0.05)。观察组总有效率[92.5%(37/40)]明显高于对照组[75.0%(30/40)](P<0.05)。两组治疗期间均未出现明显不良反应。结论:化痰散瘀汤能有效改善斑块型银屑病(痰瘀互结证)患者皮损状况,缓解瘙痒等临床症状,有助于提高生活质量,其可能与调节IFN-γ、IL-4、IL-17A、IL-10、IL-22等免疫细胞因子,纠正患者机体紊乱的免疫机能有关。展开更多
文摘Background: Basal cell carcinoma (BCC) is a frequently diagnosed skin cancer with variable histopathological types. BCC was not widely studied in Sudan as it is in the Caucasian population. Objectives: To appraise the clinical and histopathological aspects of BCC of the skin in Sudan. Materials and methods: A retrospective descriptive analysis of 84 histologically diagnosed BCC specimens seen at three hospitals in four-year duration were reviewed and classified into histological variants according to the WHO classification 2006. Data were analyzed using Statistical Package for the Social Sciences, version 23.0. Results: The mean age (±SD) of the study participants was 56 (±1.75) years, ranging from 20 to 92 years and 63.1% were females (Female to male ratio 1.7:1). The most common incidence was among the age group 51 - 60 years. The face was the primary tumor site in 89.3% with a predilection for the nasal area (31% of those in the face), followed by the trunk (6%). Out of the total, 54.8% were histologically categorized as nodular/solid, while infiltrative accounts for 11.9% followed by the superficial type (8.3%). Surgical margins were involved in 34.5% of cases and peri-neural invasion was seen in 3.6% of cases, mostly were of the infiltrative variant. Conclusion: BCC in Sudan is commonly present in the head as solid nodular histopathological variant which is correlated with worldwide distribution but has slightly younger age and female predominance;thus further studies are needed to assess risk factors in Sudanese patients and improve approaches for earlier diagnosis and better management.
文摘目的:观察化痰散瘀汤治疗斑块型银屑病(痰瘀互结证)的临床疗效及临床作用机制。方法:将皮肤科斑块型银屑病(痰瘀互结证)患者80例按随机数字表法分为观察组与对照组各40例。对照组予阿维A胶囊+糠酸莫米松软膏治疗,观察组在此基础上予化痰散瘀汤治疗。观察两组患者中医证候评分(皮损颜色、皮损肥厚浸润、瘙痒、肌肤甲错),银屑病皮损面积和严重程度指数(psoriasis area and severity index,PASI)评分,皮肤病生活质量指数调查表(dermatology life quality index,DLQI)评分,血清免疫细胞因子干扰素γ(interferonγ,IFN-γ)、白细胞介素4(interleukin 4,IL-4)、白细胞介素17A(interleukin 17A,IL-17A)、白细胞介素10(interleukin-10,IL-10)、白细胞介素22(interleukin-22,IL-22)改善状况,并统计临床疗效及不良反应发生情况。结果:两组治疗后皮损颜色、皮损肥厚浸润、瘙痒、肌肤甲错积分均明显降低(P<0.05),且观察组治疗后中医证候积分明显低于对照组(P<0.05)。两组治疗后PASI及DLQI评分均明显降低(P<0.05),且观察组明显低于对照组(P<0.05)。两组治疗后血清IFN-γ、IL-17A、IL-22水平均明显降低(P<0.05),IL-4及IL-10水平均明显升高(P<0.05),且观察组上述指标改善情况均优于对照组(P<0.05)。观察组总有效率[92.5%(37/40)]明显高于对照组[75.0%(30/40)](P<0.05)。两组治疗期间均未出现明显不良反应。结论:化痰散瘀汤能有效改善斑块型银屑病(痰瘀互结证)患者皮损状况,缓解瘙痒等临床症状,有助于提高生活质量,其可能与调节IFN-γ、IL-4、IL-17A、IL-10、IL-22等免疫细胞因子,纠正患者机体紊乱的免疫机能有关。